SUBSCRIBE
SUBSCRIBE
News   Business

GammaCan International, Inc. Reorganizes Board Of Directors

November 16, 2006 | 
1 min read

KIRYAT ONO, Israel & NEW YORK--(BUSINESS WIRE)--GammaCan International, Inc. (OTC BB: GCAN), a developer of immunotherapies for the treatment of melanoma and other cancers, today announced the reorganization of its Board of Directors.

People Asia
MORE ON THIS TOPIC
Pictured: Nasdaq headquarters in New York/iStock,
IPO
Sionna, Odyssey Join Growing 2025 IPO Class as Analysts Forecast ‘Muted’ Market
January 21, 2025
 · 
2 min read
 · 
Tristan Manalac
Art collage, hands and scales of justice. The concept of the law of the judge.
Legal
Sage Sues Partner Biogen After Unsolicited Takeover Offer
January 21, 2025
 · 
2 min read
 · 
Tristan Manalac
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Notch Therapeutics to ‘Significantly Reduce’ Workforce
January 17, 2025
 · 
104 min read
 · 
BioSpace Editorial Staff
Human hands holding colorful puzzle pieces in 80s retro collage vector illustration. Mixed media artwork for concept of cooperation, teamwork, partnership and successful solutions.
Editorial
The People Behind Biopharma’s Big Wins: Personal Stories From JPM25
January 17, 2025
 · 
4 min read
 · 
Annalee Armstrong